Cookies


ESHRE ® uses cookies to improve your browsing experience on its website, as defined in the Cookie Policy (as updated on 18/03/2024). Strictly necessary cookies are necessary for the proper functioning of the Website – therefore, you cannot refuse them. Other, non-strictly necessary cookies are only placed if you consent to their use. Read more about it in our Cookie Policy. Do you agree with our use of non-strictly necessary cookies?
Manage my cookie preferences

Don’t miss the early fee deadline for the ESHRE 2024 Annual Meeting. Register now

Sperm DNA: organization, protection and vulnerability

from basic science to clinical application

Stockholm, Sweden

21-22 May 2009

 

Presentations

 

Welcome address – sperm chromatomin in focus – Lars Bjorndahl (Sweden)

 

Sperm DNA packaging and its relationship to function – Steven Ward (USA)

 

Changes in human sperm chromatin – from testis to ejaculate and beyond – Ulrik Kvist (Sweden)

 

Sperm epigenetics – Douglas Carrell (USA)

 

The processing of sperm DNA by the zygote – Liliana Ramos (The Netherlands)

 

The Comet and TUNEL assays – Lars Björndahl (Sweden)

 

The Acridine Orange test including flow cytometry (SCSA) and chromatin staining methods – Ulrik Kvist (Sweden)

 

Use of sperm DNA tests to evaluate pre- and post-chemotherapy sperm quality – Bernard Robaire (Canada)

 

Environmental exposures impact sperm message – Melissa Perry (USA)

 

Sperm chromatin tests in relation to other semen analysis results for diagnosing male factor infertility – Lars Bjorndahl (Sweden) on behalf of Sheena Lewis (United Kingdom)

 

Usefulness of sperm chromatin tests in the context of infertility treatment strategies: IUI, IVF, ICSI – Armand Zini (Canada)

 

Where are we today and which questions remain? Clinical studies of male factor infertility – John Aitken (Australia)